Trinity Biotech PLC (TRIB)
| Market Cap | 52.25M |
| Revenue (ttm) | 86.15M |
| Net Income (ttm) | -13.01M |
| Shares Out | 38.11M |
| EPS (ttm) | 0.04 |
| PE Ratio | 34.28 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,493 |
| Open | 1.41 |
| Previous Close | 1.38 |
| Day's Range | 1.37 - 1.41 |
| 52-Week Range | 0.86 - 3.05 |
| Beta | 1.33 |
| Analysts | Buy |
| Price Target | 4.08 (+197.6%) |
| Earnings Date | Sep 8, 2022 |
About TRIB
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral... [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for TRIB stock is "Buy." The 12-month stock price forecast is 4.08, which is an increase of 197.59% from the latest price.
News
Trinity Biotech Announces Quarter 1 2022 Financial Results
DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, ...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results
Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test
DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This CE mark allows for use by healthcare professiona...
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of S...
DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, t...
Trinity Biotech Stock Surges After $45M Capital Infusion From Korea-Based Firm
Trinity Biotech plc (NASDAQ: TRIB) announced a $45 million investment and partnership with MiCo Ltd, a KOSDAQ-listed and Korea-based company. MiCo is engaged in the biomedical business through its affil...
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea
DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the “Company”), today announced a $45 million strategic ...
Trinity Biotech shares jump 6% premarket after WHO approves is rapid test for HIV
Dublin-based Trinity Biotech Plc shares TRIB, -4.24% jumped 6% premarket Monday, after the company said it has received approval from the World Health Organization for its HIV screening product, TrinScr...
Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV
DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product, TrinScreen™ HIV, from the World Health Organisation (WHO).
Trinity Biotech Announces The Successful Closing of its Debt Refinancing
DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, ...
Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were the Subject of th...
DUBLIN, Ireland, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, ...
Trinity Biotech Enters Into $81M Loan Facility To Refinance Existing Debt
Trinity Biotech plc (NASDAQ: TRIB) has entered into an $81.25 million loan facility to refinance the existing $99.9 million of exchangeable senior notes. The Company entered into an $81.25 million senio...
Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company's Exch...
DUBLIN, Dec. 15, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory ma...
Trinity Biotech Announces Results for Q2, 2021
DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 Financial Results
Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERN Conference Call Scheduled for September 9, 2021 at 11:00 am EASTERN
Trinity Biotech Provides A Business Development Update For Q2 2021
DUBLIN, Ireland, July 16, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021.
Trinity Biotech Announces Results for Q1, 2021
DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, t...
Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 Financial Results
Conference Call Scheduled for May 25, 2021 at 11:00 am EASTERN Conference Call Scheduled for May 25, 2021 at 11:00 am EASTERN
Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results
DUBLIN, Ireland, March 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets,...
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial Results
Conference Call Scheduled for March 25, 2021 at 11:00 am EASTERN Conference Call Scheduled for March 25, 2021 at 11:00 am EASTERN
5 Irish Stocks To Buy For St. Patrick's Day
For many people, St. Patrick's Day means a corned beef and cabbage dinner, a pint of Guinness and watching “The Quiet Man” for the 100th time. For investors seeking to add a breath of fresh Eire in thei...
Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test
DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia™ SARS-CoV-2 IgG ...
Trinity Biotech Announces Results for Q3, 2020
DUBLIN, Ireland, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, ...
Trinity Biotech plc to Announce Third Quarter 2020 Financial Results
Conference Call Scheduled for November 17, 2020 at 11:00 am EASTERN Conference Call Scheduled for November 17, 2020 at 11:00 am EASTERN
Trinity Biotech Announces Results for Q2, 2020
DUBLIN, Ireland, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets...